Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ampio Pharmaceuticals 9800 MOUNT PYRAMID COURT SUITE 400 ENGLEWOOD CO 80112 USA

www.ampiopharma.com Employees: 6 P: 720-437-6500

Description:

Ampio Pharmaceuticals, Inc. develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. Principal products offered by the Company include Optina, an oral drug for the treatment of diabetic retinopathy and macular edema; and Vasaloc, an oral drug for the treatment of diabetic nephropathy. Ampio Pharmaceuticals, Inc. is based in Greenwood Village, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 85
Enterprise Value, $K -4,005
Shares Outstanding, K 1,135
Annual Sales, $ 0 K
Annual Net Income, $ -8,630 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,050 K
EBIT, $ -9,580 K
EBITDA, $ -9,450 K
60-Month Beta 3.73
% of Insider Shareholders 3.30%
% of Institutional Shareholders 5.73%
Float, K 1,098
% Float 96.70%
Short Volume Ratio 0.99

Growth:

1-Year Return -96.44%
3-Year Return -99.98%
5-Year Return -99.95%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -123.70%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.48 on 03/27/24
Next Earnings Date 11/26/24 [--]
Earnings Per Share ttm -11.01
EPS Growth vs. Prev Qtr -62.09%
EPS Growth vs. Prev Year 31.11%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/12/23

AMPE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.00
Book Value/Share 4.05
Interest Coverage -0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar